Alexander Labrunerie & Co’s Merck MRK Stock Holding History

Alexander Labrunerie & Co’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$423K	Buy	3,516 +4	+0.1%	+$462	0.16%	74
2025 Q4	$370K	Buy	3,512 +14	+0.4%	+$1.31K	0.13%	78
2025 Q3	$294K	Sell	3,498 -226	-6%	-$18.6K	0.11%	87
2025 Q2	$295K	Buy	3,724 +230	+7%	+$18.3K	0.12%	81
2025 Q1	$314K	Buy	3,494 +4	+0.1%	+$373	0.14%	80
2024 Q4	$347K	Buy	3,490 +3	+0.1%	+$309	0.15%	73
2024 Q3	$396K	Buy	3,487 +3	+0.1%	+$356	0.18%	64
2024 Q2	$431K	Sell	3,484 -121	-3%	-$15.6K	0.23%	55
2024 Q1	$476K	Buy	+3,605	New	+$444K	0.27%	56

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alexander Labrunerie & Co's MRK Position: Q1 2026 in Review

Alexander Labrunerie & Co increased its Merck (MRK) stake by 0.11% in Q1 2026, buying an estimated $462 and bringing the position to 3,516 shares worth $423K. The position accounts for 0.16% of the portfolio, ranked #74.

Alexander Labrunerie & Co first reported a position in MRK in Q1 2024 and has held it in 9 quarters since. The position peaked at $476K in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Alexander Labrunerie & Co held 3,516 shares of Merck worth $423K as of Q1 2026.
Alexander Labrunerie & Co bought 4 Merck shares in Q1 2026, an estimated $462.
Merck made up 0.16% of Alexander Labrunerie & Co's portfolio in Q1 2026, its #74 holding.
Alexander Labrunerie & Co first reported a position in Merck in Q1 2024 and has held it in 9 quarters since.
Alexander Labrunerie & Co's Merck position peaked at $476K in Q1 2024.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Alexander Labrunerie & Co's 13F filing for Q1 2026, filed 18 May 2026.